Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |